MedTrace Logo

A Trial to Evaluate the Precision and Accuracy of the NBM-200 Series When Used in a Continuous Prospective Mode

NCT01917487 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2013-09-10

No results posted yet for this study

Summary

The purpose of the study is to define the precision, accuracy and variability of the NBM-200 system in non invasive blood Hemoglobin (Hb) measurements relative to the laboratory blood analyzer by comparing two consecutive Hb values obtained by the NBM system to venous values.

Conditions

Sponsors & Collaborators

  • OrSense, Ltd.

    lead INDUSTRY

Principal Investigators

  • Ohad Cohen, Prof. · The Chaim Sheba Medical Center at Tel Hashomer

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-10-31
Completion
2013-11-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01917487 on ClinicalTrials.gov